Absorbent Microbiopsy Sampling and RNA Extraction for Minimally Invasive, Simultaneous Blood and Skin Analysis
February 21st, 2019
10.8K views
In this article, we demonstrate how the absorbent microbiopsy technique is performed and how the sample can be used for RNA extraction for simple and simultaneous sampling of skin and blood in a minimally invasive manner.
Overview
This article demonstrates the absorbent microbiopsy technique for simultaneous sampling of skin and blood in a minimally invasive manner. The method facilitates the establishment of biomarkers for skin diseases while minimizing risks for clinical research participants.
Key Study Components
Area of Science
- Neuroscience
- Biotechnology
- Clinical Research
Background
- The absorbent microbiopsy technique is designed to collect samples without leaving scars.
- It requires minimal training for application.
- The method aims to improve participant safety in clinical research.
- It allows for the extraction of RNA from collected samples.
Purpose of Study
- To demonstrate the absorbent microbiopsy technique.
- To evaluate its effectiveness in collecting skin and blood samples.
- To assess its potential for biomarker establishment in skin diseases.
Methods Used
- Preparation of the microbiopsy device and sampling site.
- Application of the device to the skin with controlled pressure.
- Extraction of RNA from the collected samples using specific buffers.
- Quantitative PCR analysis to compare biomarker expression levels.
Main Results
- Minor erythema observed post-sampling, resolving within 48 hours.
- Higher white blood cell biomarker expression detected with the new technique.
- Similar skin marker expression levels compared to previous methods.
- Reliable results depend on proper application technique.
Conclusions
- The absorbent microbiopsy is effective for minimally invasive sampling.
- It shows promise for clinical applications in dermatology and pediatrics.
- Further development of the device is ongoing to enhance its utility.
Frequently Asked Questions
What is the absorbent microbiopsy technique?
It is a method for minimally invasive sampling of skin and blood.
How does this technique benefit clinical research?
It reduces risks for participants and simplifies the sampling process.
What are the main advantages of using this technique?
It requires minimal training and does not leave scars.
How is RNA extracted from the samples?
RNA is extracted using specific buffers and centrifugation methods.
What are the implications for biomarker research?
The technique may facilitate the establishment of biomarkers for skin diseases.
Executive Industry Relevance
The absorbent microbiopsy enables minimally invasive, simultaneous sampling of skin and blood, addressing key barriers in dermatological and pediatric research. This approach supports rapid biomarker discovery while reducing participant risk and operational complexity. Its simplicity and reproducibility position it as a scalable solution for early-stage translational studies and portfolio-wide biomarker initiatives.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of skin and immune cell gene expression in a single sampling event.
- Facilitates functional target validation by capturing both tissue and circulating cell markers.
- Supports predictive confidence in early biomarker identification for dermatological indications.
Screening & Assay Development
- Provides standardized, reproducible sample input for downstream RT-qPCR and gene expression assays.
- Reduces variability in sample collection, supporting assay development and cross-study comparability.
- Enables rapid, scalable sample acquisition for screening candidate biomarkers or therapeutic effects.
Translational & Preclinical Research
- Aligns with translational biomarker strategies by enabling minimally invasive, serial sampling in human studies.
- Supports continuity from discovery through preclinical validation by integrating skin and blood readouts.
- De-risks advancement decisions by providing robust, quantitative molecular data from clinically relevant tissues.
Pipeline & Workflow Integration
This method integrates at the interface of early discovery, biomarker validation, and translational research, enabling seamless progression from hypothesis testing to preclinical evaluation.
- Discovery Biology: Supports hypothesis-driven analysis of skin and immune cell gene expression in situ.
- Screening: Delivers reproducible, quantitative RNA samples for high-confidence assay development.
- Analytics: Enables RT-qPCR-based quantification of both skin and blood markers from a single sample.
- Translational Research: Facilitates minimally invasive, serial sampling for biomarker alignment in clinical cohorts.
- Enterprise Reuse: Offers a standardized, low-risk sampling platform adaptable across dermatology and immunology portfolios.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in biomarker studies.
- Operational Value: Streamlines sample collection, minimizes training requirements, and enhances reproducibility.
- Strategic Value: Improves go/no-go decision quality and accelerates early-stage research timelines.
- Portfolio Impact: Enables risk-adjusted prioritization of biomarker and target validation programs.
Implementation Considerations
- Requires basic molecular biology expertise for RNA extraction and RT-qPCR analysis.
- Needs access to standard laboratory instrumentation and off-the-shelf extraction kits.
- Demands adherence to standardized sampling duration and handling protocols for reproducibility.
- Adaptable to various skin sites and participant populations, including cosmetically sensitive and pediatric cohorts.
- Sample yield and marker detection depend on precise application and timing as described in the protocol.
Biopharma FAQs
Why does null hypothesis testing matter for RT-qPCR biomarker analysis?
Null hypothesis testing in RT-qPCR enables objective assessment of gene expression differences between skin and blood markers, supporting robust target validation. This statistical rigor is essential for distinguishing true biological effects from sampling variability. Reliable hypothesis testing underpins confidence in early biomarker discovery decisions.
How does independent variable isolation improve microbiopsy sampling workflows?
Isolating variables such as sampling duration and device application force ensures that observed gene expression changes reflect biological differences, not procedural artifacts. This control is critical for reproducibility and comparability across studies and teams. It strengthens the workflow's value in multi-site or cross-functional research settings.
What do quantitative RT-qPCR measurements enable in skin and blood analysis?
Quantitative RT-qPCR provides precise measurement of mRNA levels for both skin and blood markers from a single microbiopsy sample. This enables direct comparison of tissue and immune cell gene expression, facilitating integrated biomarker profiling. Such quantitative outputs support data-driven advancement decisions in translational research.
Why are replication requirements critical for cross-functional biomarker studies?
Replication ensures that gene expression results from microbiopsy samples are consistent and reproducible across operators and sites. This reliability is vital for cross-functional teams to trust and act on biomarker data. Meeting replication standards accelerates portfolio progression and regulatory acceptance.
Which statistical analysis capabilities are needed before implementing RT-qPCR workflows?
Teams must be equipped to perform normalization, threshold setting, and significance testing on RT-qPCR data from microbiopsy samples. These capabilities ensure that gene expression differences are meaningful and actionable. Robust statistical analysis is foundational for integrating new biomarkers into discovery and translational pipelines.
